nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AAV and hepatitis: Cause or coincidence?
|
de Jong, Ype P. |
|
|
30 |
9 |
p. 2875-2876 |
artikel |
2 |
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
|
McCafferty, Sean |
|
|
30 |
9 |
p. 2968-2983 |
artikel |
3 |
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
|
Vesin, Benjamin |
|
|
30 |
9 |
p. 2984-2997 |
artikel |
4 |
A precise and efficient adenine base editor
|
Tu, Tianxiang |
|
|
30 |
9 |
p. 2933-2941 |
artikel |
5 |
Assessing the state of Medicaid coverage for gene and cell therapies
|
Berry, Diane |
|
|
30 |
9 |
p. 2879-2880 |
artikel |
6 |
A truncated reverse transcriptase enhances prime editing by split AAV vectors
|
Gao, Zongliang |
|
|
30 |
9 |
p. 2942-2951 |
artikel |
7 |
Broadening prime editing toolkits using RNA-Pol-II-driven engineered pegRNA
|
Huang, Shisheng |
|
|
30 |
9 |
p. 2923-2932 |
artikel |
8 |
Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques
|
Zabaleta, Nerea |
|
|
30 |
9 |
p. 2952-2967 |
artikel |
9 |
Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes
|
Cheng, Qinqin |
|
|
30 |
9 |
p. 3066-3077 |
artikel |
10 |
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen
|
Taha, Zaid |
|
|
30 |
9 |
p. 2998-3016 |
artikel |
11 |
In this issue
|
|
|
|
30 |
9 |
p. 2877-2878 |
artikel |
12 |
Knockdown of MicroRNA Let-7a Improves the Functionality of Bone Marrow-Derived Mesenchymal Stem Cells in Immunotherapy
|
Yu, Yang |
|
|
30 |
9 |
p. 3095 |
artikel |
13 |
Lipid nanoparticle-mediated silencing of osteogenic suppressor GNAS leads to osteogenic differentiation of mesenchymal stem cells in vivo
|
Basha, Genc |
|
|
30 |
9 |
p. 3034-3051 |
artikel |
14 |
Macrophages as a therapeutic target to promote diabetic wound healing
|
Sharifiaghdam, Maryam |
|
|
30 |
9 |
p. 2891-2908 |
artikel |
15 |
mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells
|
Bevers, Sanne |
|
|
30 |
9 |
p. 3078-3094 |
artikel |
16 |
P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition
|
Chen, Junzhe |
|
|
30 |
9 |
p. 3017-3033 |
artikel |
17 |
Targeting glycans for CAR therapy: The advent of sweet CARs
|
Raglow, Zoe |
|
|
30 |
9 |
p. 2881-2890 |
artikel |
18 |
Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo
|
Gorsuch, Cassandra L. |
|
|
30 |
9 |
p. 2909-2922 |
artikel |
19 |
Tumor necrosis factor alpha delivers exogenous inflammation-related microRNAs to recipient cells with functional targeting capabilities
|
Zhao, Yuechao |
|
|
30 |
9 |
p. 3052-3065 |
artikel |